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The coronavirus replicase-transcriptase complex is an assembly of viral and cellular proteins that mediate the synthesis
of genome and subgenome-sized mRNAs in the virus-infected cell. Here, we report a genetic and functional analysis of
19 temperature-sensitive (ts) mutants of Murine hepatitis virus MHV-A59 that are unable to synthesize viral RNA when
the infection is initiated and maintained at the non-permissive temperature. Both classical and biochemical
complementation analysis leads us to predict that the majority of MHV-A59 ORF1a replicase gene products (non-
structural proteins nsp1–nsp11) form a single complementation group (cistron1) while the replicase gene products
encoded in ORF1b (non-structural proteins nsp12–nsp16) are able to function in trans and comprise at least three, and
possibly five, further complementation groups (cistrons II–VI). Also, we have identified mutations in the non-structural
proteins nsp 4, nsp5, nsp10, nsp12, nsp14, and nsp16 that are responsible for the ts phenotype of eight MHV-A59
mutants, which allows us to conclude that these proteins are essential for the assembly of a functional replicase-
transcriptase complex. Finally, our analysis of viral RNA synthesis in ts mutant virus-infected cells allows us to
discriminate three phenotypes with regard to the inability of specific mutants to synthesize viral RNA at the non-
permissive temperature. Mutant LA ts6 appeared to be defective in continuing negative-strand synthesis, mutant Alb
ts16 appeared to form negative strands but these were not utilized for positive-strand RNA synthesis, and mutant Alb
ts22 was defective in the elongation of both positive- and negative-strand RNA. On the basis of these results, we
propose a model that describes a pathway for viral RNA synthesis in MHV-A59-infected cells. Further biochemical
analysis of these mutants should allow us to identify intermediates in this pathway and elucidate the precise
function(s) of the viral replicase proteins involved.
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Introduction
Coronaviruses are positive-strand, enveloped RNA viruses
that infect vertebrates and are associated mainly with
respiratory and enteric disease. They have long been
recognized as important pathogens of livestock and com-
panion animals, and they are a common cause of respiratory
tract infections in humans [1–3]. More recently, a coronavirus
has been identiﬁed as the causative agent of SARS, a form of
atypical pneumonia in humans with a case fatality ratio of
approximately 10% [4]. Clearly, there is an urgent need to
develop new strategies to prevent or control coronavirus
infections, and understanding the biology, replication, and
pathogenesis of these viruses is an essential part of this
process. Murine hepatitis virus, strain A59 (MHV-A59), is a
group II coronavirus with a genome of approximately 31,400
nucleotides. The genomic RNA encodes the structural
proteins of the virus, non-structural proteins involved in
viral RNA synthesis (the nsp or replicase proteins), and
proteins that are non-essential for replication in cell culture
but appear to confer a selective advantage in vivo (accessory
proteins) [1]. In the MHV-A59-infected cell, the expression of
the replicase protein genes is mediated by translation of the
genomic RNA, and the expression of the structural protein
genes is mediated by the translation of a set of 39-coterminal
subgenomic mRNAs. The subgenomic mRNAs are produced
by a unique mechanism that involves discontinuous tran-
scription during negative-strand RNA synthesis [5–7]. The
organization and expression of the MHV-A59 genome are
illustrated in Figure 1.
The 59 proximal open reading frames (ORF) of MHV-A59
genomic RNA (ORF1a and ORF1b) are translated to produce
two large polyproteins, pp1a and pp1ab, with calculated
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Translation of the larger pp1ab involves programmed ( 1)
ribosomal frameshifting [8]. During or after synthesis, these
polypeptides are extensively processed by three virus-
encoded proteinases to produce a membrane-bound repli-
case-transcriptase complex [9]. Cleavage of the replicase
polyproteins is predicted to result in 16 end-products; nsp1–
nsp11 encoded in ORF1a and nsp12–16 encoded in ORF1b
[10]. These proteins have been shown, or are predicted to
have multiple enzymatic functions, including papain-like
proteases (nsp3), adenosine diphosphate-ribose 19-phospha-
tase (nsp3), 3C-like cysteine proteinase (nsp5), RNA-depend-
ent RNA polymerase (nsp12), superfamily 1 helicase (nsp13),
exonuclease (nsp14), endoribonuclease (nsp15), and S-adeno-
sylmethionine-dependent 29-O-methyl transferase (nsp16)
[11–20]. The crystallographic structures of SARS coronavirus
nsp5 and nsp9 have been determined and are likely to be
similar for MHV-A59 [21–23].
In the course of an infectious cycle, the MHV-A59
replicase-transcriptase complex ampliﬁes the genomic RNA
and synthesizes subgenomic mRNAs. Ampliﬁcation of the
genomic RNA involves full-length negative-strand templates,
and the synthesis of subgenomic mRNA involves subgenome-
length negative-strand templates [24,25]. The structures
engaged in the replication and transcription of positive-
strand MHV-A59 RNA have been characterized [26]. Ap-
proximately 70% of the replicating and transcribing struc-
tures that accumulate in infected cells are multi-stranded
intermediates (replicative and transcriptive intermediate
RNA, RI/TI RNA) and 30% are found in structures with
only one or very few nascent strands (native replicative and
transcriptive forms, RF/TF RNA). Although the structures
engaged in negative-strand RNA synthesis have not yet been
characterized, it is known that MHV negative-strand tem-
plates are unstable and turn over during viral replication
[27].
The cis-acting RNA elements involved in the different
phases of MHV RNA synthesis have been studied quite
extensively. It has been shown that 59- and 39-UTR, as well as
Figure 1. Organization and Expression of the MHV-A59 Genome
The structural relationships of the MHV-A59 genome and sub-genomic mRNAs are shown. The virus ORFs are depicted as lightly shaded (replicase
proteins), shaded (accessory proteins), and heavily shaded (structural proteins). The ORFs are defined by the genomic sequence of MHV-A59 as
published by Coley et al. [45]. The hatched box represents the common 59 leader sequence and the hatched circle represents the programmed ( 1)
frameshifting element. The translation products of the genome and sub-genomic mRNAs are depicted and the autoproteolytic processing of the ORF1a
and ORF1a/ORF1b polyproteins into non-structural proteins nsp1 to nsp16 is shown. A number of confirmed and putative functional domains in the
non-structural proteins are also indicated: 3CL, 3C-like cysteine proteinase; ExoN, exonuclease; HEL, superfamily 1 helicase; MT, S-adenosylmethionine-
dependent 29-O-methyl transferase; NeU, endoribonuclease; PL1, papain-like protease 1; PL2, papain-like protease 2; POL, RNA-dependent RNA
polymerase; X, adenosine diphosphate-ribose 19-phosphatase.
DOI: 10.1371/journal.ppat.0010039.g001
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Synopsis
Coronaviruses infect both humans and animals and are associated
mainly with respiratory and enteric diseases. The recent outbreak of
SARS emphasizes the need to develop new strategies to control
these infections. This paper focuses on the proteins involved in the
replication of the coronavirus genome and the production of viral
mRNAs in the host cell. These so-called replicase-transcriptase
proteins are likely to make good targets for the development of
anti-coronaviral drugs. The approach used here is to analyze
conditional, temperature-sensitive mutants of Murine hepatitis virus
that are normal at 33 8C (the permissive temperature) but are unable
to replicate and transcribe viral RNAs at 39.5 8C (the restrictive
temperature). By identifying the genetic changes responsible for
these temperature-sensitive mutations and by analyzing the precise
nature of the defect in RNA synthesis at the restrictive temperature,
the authors are able to propose a model that describes a pathway
for viral RNA synthesis in the infected cell. Further analysis of these
mutants should allow the elucidation of the precise function(s) of
the viral proteins involved.59-UTR-adjacent regions of the genome are required for
MHV replication and transcription [28,29]. Also, studies on
MHV, and other nidoviruses, have shown the critical role of
the so-called transcription-regulating sequence (TRS) ele-
ment in the discontinuous phase of the transcription process
[7,30–33]. These data show that the stability of the leader-
TRS/body-TRS duplex, which forms during the discontinuous
extension phase of negative-strand template synthesis, is an
important determinant of subgenomic mRNA abundance.
However, it is also evident from these studies that the regions
ﬂanking the TRS elements have a profound affect on the
amounts of subgenomic mRNAs that are produced. In the
context of the discontinuous-extension model [5], this is
explained as different degrees of ‘‘attenuation’’ at each of the
TRS elements during negative-strand synthesis.
In contrast, there is still very little known about the
structure, functions, and interactions of viral and cellular
proteins in the replicase-transcriptase complex as it is
engaged in different modes of RNA synthesis. As mentioned
above, bioinformatic and biochemical studies have identiﬁed
a number of (putative) enzymatic activities associated with
individual coronavirus replicase proteins, and a number of
cellular proteins have also been implicated as components of
the MHV replicase-transcriptase complex [34–36]. However,
the essential nature of some of these cellular proteins has
been questioned [37], and further work is needed to
determine the exact protein composition of the coronavirus
replicase-transcriptase complex and how the composition is
altered, or how the proteins are modiﬁed to regulate the
different activities of the complex.
In order to address these sorts of questions, we have
embarked upon a detailed analysis of temperature-sensitive
(ts) mutants of MHV-A59 that are unable to synthesize viral
RNA when the infection is initiated and maintained at the
non-permissive temperature. The essential feature of these
mutants is that they are likely to be defective in different
aspects of viral RNA synthesis and a detailed character-
ization of their genotype and phenotype should provide
insights into the mechanisms of RNA synthesis, the functions
of individual viral replicase proteins, and the protein-RNA
and protein–protein interactions that regulate the activity of
the replicase–transcriptase complex. These conditional-le-
thal mutants may also be used in a cis–trans test to deﬁne the
number of complementation groups, or cistrons, that
contribute to a speciﬁc phenotype. This sort of analysis
can also provide valuable insight into the possible pathways
that polyproteins must travel to assume functional conﬁg-
urations and has been used with success for other RNA
viruses [38].
The MHV-A59 mutants that we study have been produced
in a number of laboratories over a period of 20 years [39–41].
They have been selected to have a low efﬁciency of plaque
formation at the non-permissive temperature compared with
the permissive temperature and hence a reversion frequency
indicative of single point mutations. In this study, we describe
a complementation analysis, and by sequence analysis of both
ts virus and revertants, we identify the causal mutation for
eight of these mutants. We also describe a more detailed
phenotype for selected mutants and suggest a model that
describes the different modes of RNA synthesis during
coronavirus replication and transcription.
Results
Characterization of ts Mutants and Revertants
Table S1 lists the ts mutants of MHV-A59 used in our
collection. All the ts mutants failed to form plaques or
synthesize viral RNA when infection was initiated and
maintained at the non-permissive temperature. While many
mutants failed to form plaques at 37 8C, other mutants
formed plaques at 37 8C and were considered leaky. This
included Alb ts22 that produced pin-prick-sized plaques after
2 d at 37 8C (compared with the wild-type [wt] A59 virus,
which produced uniform plaques of 4–5 mm in diameter) and
Wu ¨ ts18, Wu ¨ ts36, and Wu ¨ ts38, which produced smaller than
wt plaques at 37 8C. However, even for these mutants, the ts
defects responsible for their RNA-negative phenotype ap-
peared to be caused by a single point mutation because each
ts mutant possessed a characteristic low reversion frequency
between 10
 4 and 10
 8 per average base [42]. The virus
produced at 37 8C by Alb ts22, Wu ¨ ts18, Wu ¨ ts36, and Wu ¨ ts38
was also ts, i.e., the efﬁciency of plating (EOP) was less than
10
 4.
For most mutants, the revertant virus obtained from
plaques formed at the non-permissive temperature had
properties identical to wt MHV-A59. One exception was
Alb ts17, which produced equal numbers of revertant viruses
causing A59-sized plaques and revertant viruses with notice-
ably smaller plaques (Figure S1). We isolated revertant viruses
from a large (A59-sized) plaque (Alb 17RL) and a small plaque
(Alb 17RS) for sequence analysis (see below). Some of the ts
mutants did not produce revertant viruses (e.g., LA ts3, Alb
ts19) or produced revertant viruses that were markedly
different from the parental MHV-A59 virus.
Complementation Analysis
We began our complementation analyses using Alb ts16, LA
ts6, and Alb ts22 because they each had a distinct ts viral RNA
synthesis phenotype (see below). Cells were singly infected or
doubly infected with two ts mutants and the cells and medium
were harvested after the completion of a single round of
replication, i.e., 8 h post-infection (hpi) at 40 8C. We also
conﬁrmed that if infection with a ts virus alone was allowed to
proceed for up to 2 h at 30 8C, and then the culture shifted to
40 8C and the virus harvested at 12 hpi, the titer we obtained
was low (;10
4 plaque-forming units [pfu]/ml). Thus, this
protocol prevented the production of revertant virus by a
second round of replication. Complementation was measured
by determining the complementation index (CI) as described
in Materials and Methods. By deﬁnition, if the mutations are
in the same cistron, the viruses will not complement each
other. On the other hand, if the mutations are in different
cistrons, the mutants will complement each other and
progeny ts virus will be recovered.
The results of six individual crosses between Alb ts16 and
LA ts6 are shown in Table 1. All of these crosses failed to show
complementation. The average CI value was 0.5 (0.5 6 0.18
SD), which is the theoretical value for two mutants with
mutations in the same cistron [43]. This CI value was obtained
using only the titers determined at 30 8C and was not
corrected for the presence of revertants (or recombinants) as
was done by others [39,44]. We found it unnecessary to make
this correction because it did not signiﬁcantly change the CI
value (at most a decrease of one tenth) and whether or not the
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these results, we concluded that Alb ts16 and LA ts6 had a
mutation in the same cistron and were, therefore, in the same
complementation group. We next determined if Alb ts22
would complement Alb ts16 or LA ts6. As shown in Table 1, in
three separate experiments Alb ts22 clearly complemented
both Alb ts16 and LA ts6. Therefore, the mutation in Alb ts22
was in a different cistron than the mutations in Alb ts16 and
LA ts6, thus identifying a second complementation group. In
a series of further experiments, we extended our comple-
mentation analysis to include Alb ts6, Wu ¨ ts18, Wu ¨ ts36, and
Wu ¨ ts38. Using the same assay, we found that Alb ts6
complemented Alb ts22 but failed to complement Alb ts16
or LA ts6. Thus, we conclude that Alb ts6 was in the same
complementation group as Alb ts16 and LA ts6. Finally, we
found that Wu ¨ ts18, Wu ¨ ts36, and Wu ¨ ts38 were in a different
complementation group(s) from that of either Alb ts6 or Alb
ts22, and thus, these mutants deﬁned at least a third
complementation group.
In our analysis of the ts mutants of MHV-A59 described
above, values for the CI were always less than two or more
than ﬁve and thus readily interpreted as positive or negative
without correction for the presence of revertants or
recombinants. However, from the results we obtained, it
was clear that recombination did occur when there was
complementation. The EOP of the virus harvested from cells
co-infected with two complementing viruses was usually
;10
 2, and not the EOP of the individual ts mutants, which
was 10
 4–10
 8. This result is in contrast to similar experi-
ments using Sindbis virus in complementation assays, where
we obtained similar EOPs to the input viruses when assaying
the progeny from complementing ts mutants (unpublished
data). We took these results to indicate that complementation
allowed recombination in MHV.
This ﬁnding provided the means to develop a more
convenient and more rapid method of determining comple-
mentation for MHV-A59 ts mutants. We reasoned that
because recombination appeared to be driven by comple-
mentation, biochemical complementation (i.e., viral RNA
synthesis) might be detected in cells co-infected with
complementing ts mutants, but not in cells infected with ts
mutants in the same complementation group. We devised
such an assay. Cells were infected at the permissive temper-
ature and were then re-fed with medium prewarmed to the
non-permissive temperature and containing dactinomycin to
inhibit DNA-dependent RNA synthesis and
3H-uridine to
label viral RNA. The infected cells were incubated until 7–8
hpi at 39 8Ct o4 08C or 8–12 hpi at 30 8C, and RNA synthesis
was measured by the incorporation of
3H-uridine into acid-
precipitable material. Figure 2A shows the results of single
and double infection with the Alb ts6, Alb ts16, Alb ts22, and
LA ts6 mutants. The data show that at 40 8C, the mutants Alb
ts6, Alb ts16, and LA ts6 were not able to rescue the RNA-
negative phenotype of each other and thus, the three mutants
were in the same complementation group. In contrast, Alb
Figure 2. Biochemical Complementation Analysis of Selected MHV-A59
ts Mutants
Cells were mock-infected or infected with MHV-A59, one of the ts
mutants, or with a mixture of two ts mutants. The cells were incubated at
40 8C in medium containing dactinomycin and
3H-uridine and, at 8 hpi,
3H-uridine incorporation into trichloroacetic acid-precipitated RNA was
determined. Cells were infected with: M, mock-infected; A59, MHV-A59;
A6, Alb ts6; A16, Alb ts16; A22, Alb ts22; A17, Alb ts17; L6, LA ts6; W18,
Wu ¨ ts18; W36, Wu ¨ ts36; W38, Wu ¨ ts38; A6xA16, Alb ts6 and Alb ts16;
A6xL6, Alb ts6 and LA ts6; A6xA22, Alb ts6 and Alb ts22; A16xL6, Alb ts16
and LA ts6; A16xA22, Alb ts16 and Alb ts22; L6xA22, LA ts6 and Alb ts22;
A17x A16, Alb ts17 and Alb ts16; A17xL6, Alb ts17 and LA ts6; A17xA22 or
A22xA17, Alb ts17 and Alb ts22; A17xW38, Alb ts17 and Wu ¨ ts38;
A17xW18, Alb ts17 and Wu ¨ ts18; A17xW36, Alb ts17 and Wu ¨ ts36;
A22xW18, Alb ts22 and Wu ¨ ts18; A22xW36, Alb ts22 and Wu ¨ ts36;
A22xW38, Alb ts22 and Wu ¨ ts38; W18xW36, Wu ¨ ts18 and Wu ¨ ts36;
W18xW38, Wu ¨ ts18 and Wu ¨ ts38; W36xW38, Wu ¨ ts36 and Wu ¨ ts38.
DOI: 10.1371/journal.ppat.0010039.g002
Table 1. Genetic Complementation Analysis of MHV-A59 ts
Mutants
Cross CI MOI (pfu/Cell)
a
Alb ts16 3 LA ts6 0.35 20 þ 20
Alb ts16 3 LA ts6 0.54 20 þ 20
Alb ts16 3 LA ts6 0.65 20 þ 20
Alb ts16 3 LA ts6 0.24 20 þ 20
Alb ts16 3 LA ts6 0.51 20 þ 20
Alb ts16 3 LA ts6 0.71 100 þ 100
LA ts6 3 Alb ts22 11 20 þ 20
LA ts6 3 Alb ts22 18 20 þ 20
LA ts6 3 Alb ts22 110 100 þ 100
Alb ts16 3 Alb ts22 121 20 þ 20
Alb ts16 3 Alb ts22 121 20 þ 20
Alb ts16 3 Alb ts22 107 100 þ 100
Alb ts6 3 Alb ts16 0.23 100 þ 100
Alb ts6 3 LA ts6 1.7 100 þ 100
Alb ts6 3 Alb ts22 694 20 þ 20
Alb ts6 3 Alb ts22 108 100 þ 100
Alb ts6 3 Wu ¨ ts18 141 20 þ 20
Alb ts6 3 Wu ¨ ts36 183 20 þ 20
Alb ts6 3 Wu ¨ ts38 1,875 20 þ 20
Alb ts22 3 Wu ¨ ts18 185 20 þ 20
Alb ts22 3 Wu ¨ ts36 240 20 þ 20
Alb ts22 3 Wu ¨ ts38 1,300 20 þ 20
aCells infected with either 20 pfu or 100 pfu of each ts virus per cell.
DOI: 10.1371/journal.ppat.0010039.t001
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ts6, Alb ts16, and LA ts6 and thus, was the sole member of a
separate complementation group. This result is identical to
that obtained using classical complementation assays and
served to validate the new method. The assay was as speciﬁc as
classic genetic complementation, which measures progeny
virus production, but is less time-consuming.
Using this assay, we were able not only to conﬁrm the
prediction of at least three complementation groups that
were obtained using classical complementation procedures
but also to identify a fourth complementation group. The
results are presented in Figure 2B and 2C and show that
mutants Alb ts17, Wu ts36, Wu ts38, and Wu ts18 deﬁne not
one but two additional complementation groups. We found
Alb ts17 and Wu ¨ ts38 belong to the same complementation
group based on their failure to complement each other’s
defects. However, both of these mutants complemented Wu ¨
ts36 and Wu ¨ ts18, which did not complement each other.
Finally, we extended this assay to include the full collection
of mutants that we have available and Table 2 summarizes the
complementation patterns of the RNA-negative ts mutants of
MHV-A59 assayed to date. The numbers shown in Table 2
represent the percentage of viral RNA synthesis found for the
mixed mutant-infected cells compared to A59 virus-infected
cells at 40 8C. A value less than zero means the
3H-uridine
incorporation was less than that obtained from mock-
infected cells. With this type of assay, we took less than 1%
of the MHV-A59 incorporation as indicating failure to
complement and greater than 1% as evidence of positive
complementation. Based on these results, it was possible to
assign a further ten mutants (Alb ts2, ts8, and ts9, and ts19; Ut
ts88 and ts329; LA ts3 and ts9; and NC ts2 and ts3) to the same
complementation group as Alb ts6, Alb ts16, and LA ts6 and, it
was possible to assign mutant Ut ts145 to the same
complementation group as Wu ¨ ts18 and Wu ¨ ts36. Thus, it
was possible to assign the entire collection of 19 RNA-
negative ts mutants of MHV to one of four complementation
groups, which we have tentatively named cistrons I, II, IV, and
VI based on the locations identiﬁed for their causal point
mutations (see below). This numbering scheme leaves open
the possibility of ﬁnding two additional complementation
groups (cistrons III and V) in the future that would represent
gene products of ORF1b (see below).
Identification of Mutations Responsible for the ts Mutant
Phenotype
The entire coding region of the replicase genes (ORF1a and
ORF1b) was sequenced for each of eight ts mutant/revertant
pairs. In each case, a single nucleotide change was identiﬁed
as the mutation responsible for the ts mutant phenotype.
Using the numbering that we have assigned to the infectious
c D N Ac l o n eo ft h eM H V - A 5 9g e n o m e[ 4 5 ]( G e n B a n k
accession number AY700211), the nucleotide changes com-
pared to wt MHV-A59 were identiﬁed as: Alb ts6, A9494! C;
Alb ts16, U10864! C; LA ts6, C13360! G; Alb ts22, A16180! G;
Alb ts17, G19288! A; Wu ¨ ts38, U19383!C; Wu ¨ ts18, C20880!U;
Wu ¨ ts36, U21304! C (Figure 3A). We also identiﬁed a number
of nucleotide differences between mutants isolated in differ-
ent laboratories, but in no case did they correlate with the ts
phenotype. With the exception of the Alb 17RS revertant, all
of the revertants we isolated were true, i.e., they were
genetically and phenotypically identical to the wt MHV-
A59. The Alb 17RS revertant was a pseudorevertant in that
the nucleotide at position 19288 had reverted from A! C,
which resulted in a substitution of Tyr with Arg. This radical
substitution was reﬂected in a small plaque phenotype
(Figure S1).
All of the nucleotide changes responsible for the ts mutant
phenotype were non-synonymous mutations. The amino acid
substitutions are shown in Figure 3B. Conservative substitu-
tions were identiﬁed in nsp5 and nsp10 of the Alb ts16 and
LA ts6 mutants, respectively. Moderately conservative sub-
stitutions were identiﬁed in nsp4 and nsp12 of the Alb ts6 and
Alb ts22 mutants, respectively. And radical substitutions were
identiﬁed in nsp14 of the Alb ts17 and Wu ¨ ts38 mutant, as well
as nsp16 of the Wu ¨ ts18 and Wu ¨ ts36 mutants [46]. A
comparison of the predicted replicase protein sequences
from different coronaviruses showed that there was, by and
large, conservation of the amino acids that were substituted
in the proteins with a ts phenotype. For example, the Gln65
residue of nsp10, the His868 residue of nsp12, and the Cys408
residue of nsp14 appear to be well conserved in Group I, II
(including SARSCoV), and III coronaviruses. In contrast, the
Asn258 residue of nsp4 is only found in MHV strains, although
in the majority of other coronaviruses, it is substituted by an
aspartic acid. Finally, it is possible, with different degrees of
conﬁdence, to predict the structural environment in which
the residues in question are found. On the one hand, it is
highly likely that the Phe219 residue of nsp5 is located in an
extended area that connects the a-helices B and C in the
carboxyl-terminal domain III of nsp5, the 3C-like proteinase.
This conclusion is based upon the similarity in the sequences
of coronavirus nsp5 proteins and the crystallographic
Table 2. Biochemical Complementation Analysis of MHV-A59 ts
Mutants
Mutants Complementation Groups
a
II I I V V I
Alb ts16 LA ts6 Alb ts22 Alb ts17 Wu ¨ ts18
Alb ts16 — 0.2 39 50 ND
Alb ts2 0.9 0.1 56 52 53
Alb ts6 0.1 0.1 41 ND ND
Alb ts80 . 4,03 1 5 0 2 8
Alb ts9 0.2 0.3 49 52 54
Alb ts19 0.1 ,03 0 3 7 1 7
Ut ts88 0.3 ,01 1 3 1 1 3
Ut ts329 0.4 ,04 5 5 7 3 0
LA ts3 0.1 0.3 22 39 14
LA ts6 ,0— 9 3 N D
LA ts90 . 1 ,0 9 37 14
NC ts20 . 1,01 5 2 5 1 5
NC ts3 ,0 0.23 6 21 6
Alb ts22 ND ND — 38 6
Alb ts17 77 7 47 — 58
Wu ¨ ts38 ND ND 15 0.3 40
Wu ¨ ts18 39 ND 6.6 42 —
Wu ¨ ts36 ND ND 7.2 37 ,0
Ut ts145 6 6 7 35 0.1
The numbers represent the percent of the incorporation found in the MHV-A59 infected cells.
a3H-uridine incorporation into trichloroacetic acid-precipitated RNA in the mock- and singly ts mutant-infected cells
was statistically indistinguishable and was combined to give an average background incorporation that was
subtracted from the MHV-A59 and the doubly infected samples.
ND, not determined.
DOI: 10.1371/journal.ppat.0010039.t002
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enteritis virus (TGEV), SARSCoV, and HCoV-229E nsp5
proteins [23,47,48]. On the other hand, programs that predict
protein secondary structure [49] indicate that the Gln65
residue of nsp10, the His868 residue of nsp12, and the Cys408
residue of nsp14 are located in disordered loop structures,
while the Asn258 residue of nsp4 and the Leu153 residue of
nsp16 are involved in a-helices. Obviously, more deﬁnitive
structural data will be needed to conﬁrm these predictions.
Phenotypes of the MHV-A59 ts Mutants
We focused our phenotypic analysis on the eight MHV-A59
ts mutants that had been genotyped and began by measuring
‘‘total’’ viral RNA synthesis in infected cells prior to and
following shift from the permissive to the non-permissive
temperature. This analysis was done after 8 h of incubation at
30 8C, a time at which the replicase-transciptase complex
produces mainly (.90%) positive-strand RNA, and ;20% of
the maximum rate of RNA synthesis has been reached.
Mutant virus-infected cells were shifted to 40 8C at 8 hpi and a
duplicate set was left at 30 8C. Both sets of cultures were
labeled for 1 h with
3H-uridine in the presence of 10 lg per
ml of cycloheximide (CH) to monitor the replicase-tran-
scriptase activity at the time of shift. The results are shown in
Figure 4. In MHV-A59 infected cells, the amount of
3H-
uridine incorporation doubled, as expected, when the
temperature was increased by 10 8C. The group I mutants
had about the same level of viral RNA synthesis at both
temperatures, while in the group II, IV, and VI mutant-
infected cells, viral RNA synthesis diminished by 50% or
more in the hour following temperature shift. We interpret
Figure 3. Genotypic Analysis of Selected MHV-A59 ts Mutants
(A) The positions of mutations responsible for the ts phenotype of selected MHV-A59 mutants are illustrated in relation to the non-structural proteins
(nsp1–16) produced by proteolytic processing of the ORF1a/ORF1b polyprotein, pp1ab. Nucleotide changes are numbered according to the sequence
of the infectious cDNA clone of MHV-A59.
(B) The amino acid substitutions responsible for the mutant and revertant phenotypes are listed together with the mutated protein and the cistron to
which each mutant has been assigned. The amino acids are numbered from the amino-terminus to the carboxyl-terminus of each of the non-structural
proteins.
DOI: 10.1371/journal.ppat.0010039.g003
Figure 4. RNA Synthesis Phenotype of MHV-A59 ts Mutants
RNA synthesis was determined using a 1 h pulse label with
3H-uridine in
the presence of dactinomycin and cycloheximide, given to wt MHV-A59
and ts mutant virus-infected cells at 8 hpi with or without shifting from
the permissive to the non-permissive temperature. The amount of
incorporated
3H-uridine at 40 8C was divided by that at 30 8C and 1.0 was
subtracted. The results represent the average of five separate experi-
ments. A value of zero means the incorporation at the two temperatures
was the same.
DOI: 10.1371/journal.ppat.0010039.g004
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ORF1a appeared to confer temperature-sensitivity to the
viral replicase-transcriptase complex, but once it had formed
at 30 8C, its positive-strand synthetic activity was relatively
resistant to higher temperature. In contrast, mutations in
ORF1b-encoded proteins, namely nsp12, nsp14, and nsp16
appeared to affect the positive-strand synthetic activity of
already-formed replicase-transcriptase complexes. We then
went on to analyze the phenotypes of three ts mutants in
more detail.
Alb ts22. The phenotype described above for group II, IV,
and VI mutants would be consistent with a defect in any stage
of positive-strand RNA synthesis. In the case of mutant Alb
ts22, however, we have shown that the ts lesion is located in
nsp12, the viral RNA-dependent RNA polymerase subunit.
This suggested to us that the Alb ts22 might be defective in
the elongation phase of RNA synthesis. To analyze the
phenotype of Alb ts22 in more detail, RNA synthesis in Alb
ts22-infected cells was determined using 1 h pulse labels with
3H-uridine in the presence of dactinomycin, given between
1–6 hpi at 40 8C or between 5–14 hpi at 30 8C (Figure 5A). At
40 8C, Alb ts22-infected cells incorporated only mock levels of
3H-uridine, as expected for an RNA-negative ts mutant. In
contrast, cells infected with wt MHV-A59 or with Alb 22R (a
revertant of Alb ts22) made RNA at high rates and at identical
times. At 30 8C, Alb ts22 was defective in viral RNA synthesis
and never reached the levels of viral RNA synthesis shown by
wt MHV-A59 or Alb 22R. These results are consistent with
our ﬁnding that, at 30 8C, the plaques formed by Alb ts22 were
smaller that those formed by wt MHV-A59. Analysis by gel
electrophoresis of the species of positive-strand RNA made in
Alb ts22-infected cells at 30 8C showed the typical pattern of
seven RNAs (genome and six subgenomic mRNAs), although
the six subgenomic mRNAs were reduced equally in amount
relative to the genome RNA when compared to Alb 22R
infected cells (unpublished data). We conclude that Alb ts22
not only produced less overall RNA compared to wt MHV-
A59 and Alb 22R, even at the permissive temperature, but
also under-produced all of the subgenomic mRNA species
relative to the genome RNA.
We also examined the ability of Alb ts22-infected cells to
continue viral RNA synthesis after shift from 30 8Ct o4 08Ca t
13 hpi (Figure 5B). This allowed us to follow the activity at 40
8C of the viral RNA-dependent RNA polymerase that was
made and assembled at 30 8C. At this time, Alb ts22 RNA
synthesis was at its maximum rate and RNA synthesis by wt
MHV-A59 and Alb 22R was declining. The results show that a
shift to 40 8C led to the rapid loss of RNA synthesis by Alb ts22
but not by wt MHV-A59 or Alb 22R. This result is consistent
with a failure of the viral RNA-dependent RNA polymerase to
continue transcription at the non-permissive temperature.
We concluded Alb ts22 had a ts defect in elongation, although
we do not know if elongation is directly affected or if the
amino acid change in nsp12 affects its interaction with an as
yet unknown, but essential protein. We have also shown that,
as expected, Alb ts22 is unable to synthesize negative-strand
RNA at the non-permissive temperature (unpublished data).
Alb ts16 and LA ts6. Although both Alb ts16 and LA ts6 are
unable to synthesize viral RNA when the infection is initiated
and maintained at the non-permissive temperature, the data
shown in Figure 4 suggests that they are not signiﬁcantly
impaired in their ability to synthesize positive-strand RNA at
this temperature. This conclusion is strengthened by the
results shown in Figure 6A, which demonstrate the kinetics of
overall viral RNA synthesis in Alb ts16 and LA ts6 virus-
infected cells after shifting the incubation temperature from
30 8Ct o4 08C at 8 hpi. With wt MHV-A59, viral RNA synthesis
increased rapidly within the ﬁrst 60 min after temperature
shift, consistent with the synthesis of both additional
negative-strand templates and their nascent positive-strand
product. The addition of CH at the time of shift resulted in a
constant rate of viral RNA synthesis for at least 1 h. As we
know that negative-strand synthesis in MHV-A59-infected
cells is short-lived and stops within 30 min of the inhibition of
protein synthesis [24], we deduce that the addition of CH
prevented the synthesis of new viral proteins, which in turn
prevented the formation of additional replicase-transcriptase
activity and negative-strand templates.
In cells infected with complementation group I ts mutants
Alb ts16 and LA ts6, viral RNA synthesis continued at 40 8Ca t
the level ongoing at the time of temperature shift (Figure 6A).
This meant that the replicase-transcriptase complexes
assembled at 30 8C continued to function at 40 8C in the
synthesis of positive-strand RNA. However, unlike A59-
infected cells, the group I mutants did not increase their
rates of RNA synthesis after shift to non-permissive temper-
ature, indicating that no new active complexes were formed.
This phenotype resembled that seen with MHV-A59-infected
cells treated with CH, and we conclude that the complemen-
tation group I mutants are defective in their ability to form
active replicase-transcriptase complexes at 40 8C but retain
the positive-strand synthesis activity of the complexes formed
at the permissive temperature.
At least two possibilities could account for a failure of
group I ts mutants to form fully competent replicase-
transcriptase complexes at the non-permissive temperature.
Either no new negative-strand templates were made, i.e., a
defect in negative-strand synthesis, or, if they were made, they
could not be used as templates for positive-strand synthesis.
Figure 5. RNA Synthesis Phenotype of the Alb ts22 Mutant
RNA synthesis was determined (A) using 1 h pulse labels with
3H-uridine
in the presence of dactinomycin, given to MHV-A59-, Alb ts22-, and Alb
22R-infected cells 1–6 hpi at 40 8C or 5–14 hpi at 30 8C; n,4 08C, wt MHV-
A59; m,4 08C, Alb 22R; ,4 08C, Alb ts22; u,3 08C, wt MHV-A59; n,3 0
8C, Alb 22R; .,3 08C, Alb ts22, or (B) using 30 min pulse labels with
3H-
uridine in the presence of dactinomycin, given to MHV-A59-, Alb ts22-,
and Alb 22R-infected cells after shift from the permissive to the non-
permissive temperature at 13 hpi; n, wt MHV-A59; m, Alb 22R;  , Alb
ts22.
DOI: 10.1371/journal.ppat.0010039.g005
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rus mutants [50], which were called conversion-defective
mutants. To distinguish between these two possibilities, it is
necessary to shift the ts mutant-infected cells to the non-
permissive temperature and determine their ability to
continue negative-strand RNA synthesis. Mutants that fail to
continue negative-strand RNA synthesis would be defective in
this step, while mutants that continued to make negative
strands would be designated as conversion-defective mutants.
Cells infected with wt MHV-A59, Alb ts16, and LA ts6 were
shifted from 30 8Ct o4 08C at 8 h (Alb ts16) or 9 h (LA ts6)
post-infection and were pulse-labeled with
3H uridine at 40
8C. Then, viral negative-strand templates in replicating and
transcribing structures were puriﬁed free of single-stranded
RNA, and the incorporation of radioactivity into negative-
stranded RNA was measured by nuclease protection assays. In
this assay, the results are expressed as the percentage of the
3H-uridine incorporated into the negative-stranded compo-
nent of the puriﬁed, nuclease-resistant RNA cores of the
replicative-transcriptive structures. As these structures rep-
resent double-stranded RNA, if 40%–50% of the total
incorporation in the core RNA is found in negative strands,
it means that 80%–100% of the negative strands that were
active as templates during the pulse period had been made
during this same period. This occurred when negative-strand
synthesis was measured early in the infection cycle, when viral
RNA synthesis was ;20% of the maximum [24].
Figure 6B shows that in wt MHV-A59-infected cells,
negative-strand synthesis continues following a shift from
30 8Ct o4 08C at a time when the amount of viral RNA
synthesis is ;20% of maximum. This is seen by the similar
high values of 20%–25% of the labeled RF RNA being in
negative strands for successive 30 min pulse-periods in the
absence of CH. Also, as shown previously, continued negative-
strand synthesis in MHV-A59-infected cells is dependent on
continued translation and abruptly declines in the presence
of CH. In the case of LA ts6, the percentage of
3H-uridine
incorporated in negative strands declined abruptly after
shifting to 40 8C and this decline was the same in the absence
or the presence of CH. With Alb ts16, negative-strand
synthesis continued during the 20–40 min and the 40–60
min pulse-periods in the absence of CH but was inhibited in
the presence of CH. For this mutant, to ﬁnd that negative-
strand synthesis continued at 40 8C without an increase in the
rate of positive- strand synthesis, as seen for MHV-A59, was
consistent with Alb ts16 having a ts defect affecting the ability
of the negative-strand templates to be efﬁciently used at 40
8C. Thus, we conclude that LA ts6 was defective in continuing
negative-strand synthesis after shift to 40 8C and Alb ts16
displayed what appears to be a conversion phenotype.
Discussion
Taken together with the complementation analysis, the
identiﬁcation of the mutations responsible for the ts
phenotypes of Alb ts6, Alb ts16, Alb ts17, Alb ts22, LA ts6,
Wu ¨ ts18, Wu ¨ ts36, and Wu ¨ ts38 leads to a number of important
conclusions. First, our data strongly suggest that most of the
replicase gene products of ORF1a are cis-active and form a
single complementation group (cistron I) encompassing, at
least, the nsp4 to nsp10 coding region. If correct, our
conclusion must mean that a large proportion of nsp1–
nsp11 proteins function as a polyprotein, if only initially or
transiently, or they associate as a cis-acting complex before
they are proteolytically processed. We favor a model in which
a pp1a-related polyprotein represents a large modular
scaffolding protein that displays binding sites for ORF1b-
encoded pp1ab processing products. While the large number
of mutants that fall into cistron I clearly suggest that it is
extensive and polygenic, it is not yet clear if all of the ORF1a-
encoded proteins function in cis. We are aware that the
arterivirus Equine arteritis virus ORF1a-encoded protein
nsp1 can function in trans [51] and it has recently been shown
that the MHV-A59 ORF1a-encoded protein nsp2 is non-
essential for virus replication [52]. The genetic analysis of
further MHV-A59 ts mutants will be needed to deﬁne the
precise boundaries of MHV-A59 cistron I.
Second, our results suggest that the replicase gene products
encoded in ORF1b (i.e., nsp12–nsp16) are diffusible and thus
assemble and function in viral RNA synthesis after cleavage
from pp1ab. This also leads us to the prediction that there
Figure 6. RNA Synthesis Phenotype of the Alb ts16 and LA ts6 Mutants
RNA synthesis (A) or negative-strand RNA synthesis (B) was determined
using 20 or 30 min pulse labels with
3H-uridine in the presence of
dactinomycin, with or without the addition of CH, after shifting the
incubation temperature of MHV-A59-, Alb ts16-, and LA ts6-infected cells
from 30 8Ct o4 08C at 8 hpi: filled bar, 0–20 min pulse; grey bar, 20–40
min pulse; open bar, 40–60 min pulse; dark diagonal bar, 0–30 min pulse;
light diagonal bar, 30–60 min pulse.
DOI: 10.1371/journal.ppat.0010039.g006
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the proteolytic cleavage products, and we have designated
them tentatively as cistrons II–VI in a 59 to 39 direction
(nsp12, cistron II; nsp13, cistron III; nsp14, cistron IV; nsp15,
cistron V; and nsp16, cistron VI). The idea that the MHV-A59
ORF1b-encoded replicase proteins function in trans is
consistent with the results of Brockway et al., who have
shown that a green ﬂuorescent protein–tagged MHV-A59
nsp12 is able to diffuse into the replicase-transcriptase
complex if expressed individually in virus-infected cells [9].
However, we would also like to note that our data does not
exclude the possibility that some of the ORF1b-encoded
proteins may function as intermediates, rather than the end
products of proteolytic cleavage. For example, functional
proteins comprising nsp12/nsp13, nsp13/nsp14, nsp14/nsp15,
nsp15/nsp16 as well as nsp13/nsp14/nsp15 could all be
accommodated as single cistrons based upon our comple-
mentation data. This would lead to the prediction of either
three or four cistrons encoded in ORF1b. The idea that a
number of the enzymes involved in coronavirus RNA
synthesis may be linked not only functionally, i.e., sequentially
in a concerted reaction pathway, but also structurally (i.e., as
multifunctional proteins) is also suggested by other studies.
For example, Ziebuhr and colleagues [53] have shown that 29-
O-ribose-methylated RNA substrates are resistant to cleavage
by the SARS-coronavirus endoribonuclease (nsp15), indicat-
ing a functional link with the S-adenosylmethionine-depend-
ent 29-O-methyl transferase (nsp16). We are currently
searching for further ts mutants that might help resolve this
issue and we are attempting to trans-complement ts mutants
with cell lines that constitutively express ORF1b-encoded
replicase proteins. Despite these reservations, the genetic
data do allow us to conclude that not only nsp5, the 3C-like
cysteine proteinase, and nsp12, the putative RNA-dependent
polymerase (as might have been predicted), but also nsp14,
the putative MHV exonuclease, nsp16, the putative MHV 29-
O-methyltransferase, nsp4, and nsp10 are essential for the
assembly of a functional replicase-transcriptase complex.
In contrast to most other positive-stranded RNA virus, the
viral replicase-transcriptase complex of coronaviruses (and
most other nidoviruses) functions to amplify the genome via a
full-length negative-strand intermediate and to produce, via a
discontinuous process, subgenome-length negative-strand
templates that are then copied directly into subgenomic
mRNA. How the replicase-transcriptase complex accom-
plishes these various activities is not understood in any
detail. For example, it is not known whether the same
replicase-transcriptase complex functions to produce full-
length and subgenome-length RNA or how the conversion
from negative- to positive-strand RNA synthesis is regulated.
Does the analysis of MHV-A59 ts mutants help us to
understand these complex processes?
We have shown previously that negative- and positive-
strand RNA synthesis occurs simultaneously throughout
MHV-A59 infection but that negative-strand synthesis is
short-lived, i.e., its synthesis halts within several minutes after
protein synthesis is inhibited [24]. This contrasts with
positive-strand synthesis, which continues unabated for 1 h
and then gradually declines and disappears about 4 h after
the inhibition of translation. These observations suggest that
unprocessed forms of the replicase polyprotein(s) might
function in negative-strand synthesis and that cleavage of the
nascent polyprotein inactivates the negative-strand activity of
the replicase, as it does for alphaviruses [54,55]. The replicase-
transcriptase activity for positive-strand synthesis can be
restarted after the block of translation is reversed [27] but, for
this to happen, new negative-strand templates need to be
synthesized. In other words, it appears that the coronavirus
replicase-transcriptase complex ages, losing both its negative-
strand templates and its activity. This interpretation ﬁts well
with our genetic analysis of the mutants LA ts6, Alb ts16, and
Alb ts6, which shows that they all fall into a single
complementation group. It is also consistent with our
proposal that the replicase proteins encoded in ORF1a are
expressed and function as a polyprotein, or that they
assemble as a cis-acting complex before they are proteolyti-
cally processed. It is also worth noting that in vivo protein
labeling experiments indicate that proteolytic processing of
both MHV-A59 ORF1a and MHV-A59 ORF1b-encoded
replicase proteins is measured in hours rather than minutes
[56–58] and that the fully processed 3C-like cysteine
proteinase is ﬁrst detected several hours post-infection [59],
a time at which the rate of viral RNA synthesis is already
increasing rapidly [24].
The idea that the MHV replicase-transcriptase complex is
active in negative-strand RNA synthesis before pp1a is
extensively processed also ﬁts well with our detailed
phenotypic analysis of cistron I mutants. In the case of LA
ts6, negative-strand synthesis was inhibited after shift to the
non-permissive temperature and, in time, this leads to a
decline in positive-strand RNA synthesis (unpublished data).
Thus, at the non-permissive temperature, LA ts6 could not
sustain positive-strand synthesis, nor replace or replenish
aging replicase-transcriptase complexes. The causal mutation
in LA ts6 would substitute a Glu for the Gln65 residue of wt
nsp10. As noted above the Gln65 residue is conserved in
Group I, II (including SARSCoV), and III coronaviruses and
its substitution with Glu might prevent the proper folding of
pp1a into a conformation that would allow it to participate in
the formation of a replicase-transcriptase complex with
negative-strand activity. It would be interesting to determine
if, at the non-permissive temperature, nsp10 of LA ts6 could
associate with nsp12, nsp13, nsp14, nsp15, or nsp16. Also, it
was curious that LA ts6 had a very low reversion frequency of
;10
 8. Why certain bases fail to revert at the typical
frequency of 10
 4 to 10
 5 is unknown but may be indicative
of a region of the genome that is transcribed with higher
ﬁdelity than other regions. Alternatively, this low reversion
frequency may be an inherent property of the LA ts6
replicase-transcriptase complex.
In contrast to LA ts6, Alb ts16 appeared to be able to
continue to form negative strands after shift to the non-
permissive temperature, but these negative strands were not
converted into templates for positive-strand synthesis. We
speculate that Alb ts16 has a ts defect in the conversion of the
replicase-transcriptase complex from one able to synthesize
negative strands to one able to synthesize positive strands. It
is certainly suggestive that Alb ts16 had a mutation in nsp5,
which is the 3C-like proteinase of the virus, but it has yet to
be determined if this mutation affects the activity of the
proteinase, or if it affects the folding of pp1a or pp1ab, or if
the nsp5 C-terminal domain itself could have a function in
positive-strand RNA synthesis. Nevertheless, because nega-
tive-strand RNA synthesis was inhibited in Alb ts16-infected
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temperature, we propose that the Alb ts16 replicase-tran-
scriptase complex does not retain its activity for minus-strand
synthesis. Rather it fails to gain positive-strand synthesis
activity at the non-permissive temperature. We favor a model
where the activity that makes positive strands is gained at the
expense or loss of the activity to make negative strands.
Finally, although we are able to rationalize the genotype of
Alb ts22, i.e., a mutation in nsp12 (the RNA dependent RNA
polymerase) with its phenotype (i.e., an immediate effect on
RNA synthesis at the non-permissive temperature) we were
surprised to ﬁnd that Alb ts17, Wu ¨ ts18, Wu ¨ ts36, and Wu ¨ ts38
also showed the same phenotype but had mutations in other
replicase proteins. Generally, it is unusual to ﬁnd so many ts
mutants that show an effect on RNA synthesis if the replicase-
transcriptase complex is ﬁrst allowed to assemble at the
permissive temperature. Most RNA-negative ts mutants of
alphaviruses, for example, fail to make viral RNA when the
infection is initiated at the non-permissive temperature but
continue to make viral RNA if shifted to the non-permissive
temperature late in infection (unpublished data). One
possibility is that nsp14 and nsp16 dissociate or become less
tightly associated with the replicase-transcriptase complex
after shifting to the non-permissive temperature and this
causes the complex to lose elongation activity. Another
possibility is that the enzymatic activities associated with
nsp14 and nsp16 are altered in the group IV and group VI
mutants. Further studies will be required to explain this
phenotype.
In summary, our detailed phenotypic analysis of MHV-A59
ts mutants allows us to propose a working model that
describes a pathway for viral RNA synthesis in MHV-A59-
infected cells. In this model, the replicase-transcriptase
complex forms initially and creates a negative-strand
template. It is then converted to utilize the negative strand
as a template for positive-strand synthesis and, ﬁnally, the
complex is inactivated by the degradation of negative-strand
templates (Figure 7). Our analysis also allows us to place some
of our ts mutants at speciﬁc points on this pathway. We hope
that a more detailed biochemical analysis of these mutants
will allow us to identify intermediates in the pathway of RNA
synthesis and will provide valuable information of the precise
function(s) of the viral replicase proteins involved. Further-
more, we believe that the characterization of these mutants
provides an excellent starting point for the generation of
second site reversion mutants. This could be done, for
example, by using the recently developed MHV reverse
genetic system [45] to generate ts mutants with codon, rather
than nucleotide substitutions. Second site reversion mutants
may then provide valuable information on protein-protein
interactions within the replicase-transcriptase complex.
Materials and Methods
Cells and viruses. Seventeen clone one (17Cl-1) mouse ﬁbroblast
cells [60] were cultured at 37 8C in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 6% fetal bovine serum (FBS),
5% tryptose phosphate broth (TPB), penicillin (100 units/ml), and
streptomycin (100 lg/ml). Sac( ) cells [61] were cultured at 37 8Ci n
minimal essential medium (MEM) supplemented with 5% FBS,
penicillin (100 units/ml), and streptomycin (100 lg/ml). The A59
strain of MHV and a set of ts mutants derived from MHV-A59 (Alb
preﬁx) were originally obtained from the laboratory of L. Sturman,
Wadsworth Center for Laboratories and Research, Albany, New York,
United States [40]. Mutants preﬁxed with LA (Los Angeles) and NC
(North Carolina) were obtained from M. Schaad and R. Baric,
University of North Carolina, Chapel Hill, North Carolina, United
States and have been initially characterized [39]. Mutants preﬁxed
with Ut (Utrecht) were obtained from W. Spaan, Leiden University
Medical Center, Leiden, The Netherlands and have been initially
characterized [41]. The LA, NC, and Ut ts mutants were derived from
different but related lineages of the Albany isolate of MHV-A59.
Mutants preﬁxed with Wu ¨ (Wu ¨rzburg, Germany) were isolated as
described below.
For our studies, virus stocks were derived from the original mutant
isolates after plaque puriﬁcation and propagation in 17Cl-1 cells
cultured at 30 8Co r3 38C in low pH DMEM (pH 6.4) containing 6%
FBS, 5% TPB, penicillin (100 units/ml), and streptomycin (100 lg/ml)
[24]. Revertants were picked from plaques of mutants titered at 39.5
8C, followed by another plaque puriﬁcation at 39.5 8C. The virus
stocks used were ﬁrst passage and were obtained by using virus from a
single plaque (;10
7 pfu) to infect a dish of ;4 3 10
7 17Cl-1 cells to
yield 30 ml of stock virus with a titer of 1–6 3 10
9 pfu/ml.
Isolation of Wu ¨ ts mutants. Sac( ) cells were infected with 10 pfu/
cell of MHV-A59 (originally obtained from P. Carthew, Medical
Research Council Laboratories, Carshalton, United Kingdom), and
incubated for 15 h at 37 8C in medium containing 150 lg/ml of 5-
ﬂuorouracil. This concentration of pyrimidine analogue was deter-
mined to inhibit virus replication by 80%. The mutagenized virus
stock was diluted to 15 pfu/ml in medium and 100 ll aliquots were
incubated with 10
4 Sac( ) cells at 30 8C for 48 h. The supernatant was
taken from cultures that displayed syncytium formation and used to
infect duplicate cultures of 10
4 Sac( ) cells that were incubated at 30
8C or 39.5 8C for 24 h. The supernatant was taken from replica
cultures that developed cytopathic effect at 30 8C but not at 39.5 8C,
and potential ts mutants were isolated by two plaque puriﬁcations.
Sequence analysis of the Wu ¨rzburg strain of MHV-A59 suggests that
approximately 8,000 nucleotides at the 59 end of the genome have
been exchanged by recombination with a related but different MHV
strain (unpublished data).
Characterization of mutant stocks for titer and EOP. 17Cl-1 cells in
60 mm petri dishes were infected with 0.5 ml of 10-fold dilutions of
Figure 7. A Model to Describe the Pathway for Viral RNA Synthesis in
MHV-A59-Infected Cells
Shows a working model that describes a pathway for viral RNA synthesis
in MHV-A59-infected cells. The model proposes that the replicase-
transcriptase complex forms initially and creates a negative-strand
template. It is then converted to utilize the negative strand as a template
for positive-strand synthesis and, finally, the complex is inactivated by
the degradation of negative-strand templates. It is also proposed that
proteolytic processing of the replicase polyproteins plays a role in
regulation of this pathway. Also depicted are the putative defects of
specific MHV-A59 ts mutants. It remains to be shown whether or not the
group IV and VI mutants (Wu ¨ ts38, Alb ts17, Wu ¨ ts18, and Wu ¨ ts36) are
defective in negative-strand RNA synthesis at the non-permissive
temperature.
DOI: 10.1371/journal.ppat.0010039.g007
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(MEM with Hank’s balanced salts [HBSS] containing 50 lg/ml of
DEAE-dextran [diethylaminoethyl dextran], 0.2% bovine serum
albumin, and 20 mM HEPES [N-2-hydroxyethylpiperazine-N9-2-
ethansulfonic acid] [pH 6.6]). The inoculum was removed after 30
min and the cells were overlaid with DMEM containing 6% FBS,
penicillin (100 units/ml), streptomycin (100 lg/ml), and 0.1% Gelritee
gellan gum (Sigma, St. Louis, Missouri, United States) and incubated
at the appropriate temperature in 7.5% CO2. After incubation for 3
or 4 d at 30 8Co r2da t3 78C or 39.5 8C, cells were rinsed with 0.15 M
NaCl, ﬁxed with methanol, and stained with a solution of 0.2%
toluidine blue, 0.2% azure blue, and 1% boric acid. The EOP was
calculated by dividing titers at 39.5 8C by the titer at 30 8C. We found
that all of the ts mutants produced the same titer at 30 8Ca sa t3 38C
and in all cases 6 39 8C was non-permissive for plaque formation of
the ts mutants.
Complementation analysis. Classic or genetic complementation
was done by infecting 17Cl-1cells in 35 mm petri dishes either singly
with each mutant or doubly with two mutants at a multiplicity of
infection (MOI) of 20–30 pfu/cell. After incubation at room temper-
ature or 30 8C for 30 min, the virus inoculum was removed and the
infected cells were rinsed with HBSS and re-fed with low pH DMEM
or DMEM supplemented with 6% FBS, penicillin (100 units/ml), and
streptomycin (100g/ml). The infected cells were incubated at 39.5 8C
or 40 8C in 10% CO2. One hour later the cells were rinsed again and
re-fed with warmed medium and the dishes returned to the incubator
until 8 hpi. The medium was harvested, clariﬁed at 10,000 rpm for 5
min, and virus titers were determined by plaque assays at 30 8C. CIs
were calculated using the following formula:
CI ¼
½A3B 
½A þ½ B 
ð1Þ
A CI greater than two between mutant pairs was consistent with
complementation, i.e., 6 4-fold difference above background, while a
CI less than two was negative for complementation [43].
Biochemical complementation was done by mock-infecting or
infecting 17Cl-1cells at 30 pfu/cell with MHV-A59, or one of the ts
mutants, or with a mix of 15 pfu/cell each of two ts mutants. After the
adsorption period at room temperature for 30 min, the virus
inoculum was removed, 1 ml of prewarmed medium containing
dactinomycin and
3H-uridine (1.85 MBq/ml) was added and the cells
were incubated at 40 8C. The wt and the ts mutant-infected cells were
harvested at 8 hpi and the
3H-uridine incorporation into trichloro-
acetic acid-precipitated RNA was determined.
Viral RNA synthesis. Viral RNA synthesis was measured by
determining the amount of
3H-uridine incorporated in the presence
of dactinomycin (20 lg/ml) into acid-precipitable material. [5-
3H]
uridine ( 1.0 TBq/mmol) was added to the medium at either 1.85 or
7.4 MBq/ml. After incubation, the radioactive medium was removed
and the cells dissolved with 5% lithium dodecyl sulfate and 200 lg/ml
proteinase K in LEH buffer (0.1 M LiCl, 0.001 M EDTA, 0.01 M
HEPES, [pH 6.6]) at 2–5 3 10
5 cells per ml. The DNA was sheared by
repeated passage through a 27-gauge needle attached to a 1-ml
tuberculin syringe. Triplicate samples of 5 3 10
4 cells were
precipitated with trichloroacetic acid and the precipitates collected
on glass ﬁber ﬁlters (Whatman Incorporated, Clifton, New Jersey,
United States), dried under a heat lamp, and the radioactivity
determined by liquid scintillation spectroscopy. To measure neg-
ative-strand synthesis, the dissolved cells were extracted with low pH
phenol (pH 4.3), which removed DNA from the aqueous phase, and
then with cholorofom:isoamyl alcohol (95:5), and the RNA was
precipitated with ethanol. RF RNA was generated by treatment of the
RNA with RNase T1 (1U/ug RNA, 30 8C for 30 min in 0.3 M NaCl) and
collected by chromatography on CF-11 cellulose and ethanol
precipitation. The incorporation of
3H-uridine into negative strands
was measured by denaturing the RF RNA with heat and annealing in
the presence of .100-fold excess of unlabeled RNA obtained from
puriﬁed virions of MHV [24].
Isolation of viral RNA. Two different procedures were used to
obtain viral RNA for RT-PCR and sequencing. Virions were puriﬁed
from ;3 3 10
8 17Cl-1 cells that had been infected at a MOI of ;10
pfu/cell and incubated in low pH DMEM at 30–33 8C. The medium
from the infected cells (;225 ml) was collected at 24 hpi and clariﬁed
at 4,000 rpm for 30 min. The virions were pelleted by centrifugation
at 24,000 rpm for 3 h at 4 8C. The virus pellet was allowed to suspend
overnight on ice in 0.4 ml/tube of 0.15M NaCl and 20 mM HEPES (pH
6.6). The suspended virus from six tubes was pooled and layered over
one SW28 tube containing a linear gradient of 40% potassium
tartrate (bottom) and 20% glycerol (top), in 0.0.2 M HEPES (pH 7.4).
After centrifugation at 24,000 rpm for 3–4 h at 4 8C, the visible band
containing the virions was collected, diluted, and pelleted by
centrifugation at 24,000 rpm for 3 h at 4 8C. The pelleted virions
were suspended in 0.15M NaCl and 20 mM HEPES (pH 6.6), and LiDS
and proteinase K were added to 5% and 400 lg/ml, respectively, After
incubation at 42 8C for 10 min, the viral RNA was extracted with
phenol followed by chloroform:isoamylalcohol (19:1). Viral RNA was
ethanol-precipitated and the pellet was washed with 70% ethanol,
dried under vacuum, and resuspended in water. Alternatively,
10
7 17Cl-1 cells were infected with virus, incubated for 13 h at 30
8Ct o3 38C in 7.5% CO2. The poly(A)-containing RNA was then
isolated from the infected cells using oligo-dT25 Dynabeads as
described previously [62].
RT-PCR and sequencing. The entire replicase gene-coding region
(ORF1a and ORF1b) was sequenced for eight ts mutant and revertant
pairs. To do this, we used a set of 121 synthetic oligonucleotides that
are complementary to sequences spaced at approximately 350
nucleotide intervals along the positive- and negative-strand copies
of the viral RNA (sequences available on request). Five oligonucleo-
tides, P17, P31, P46, P61, and P65, were used to prime the RT of viral
RNA with Superscript II RT (Invitrogen, Carlsbad, California, United
States). The reaction mix (20 ll), which contained, in addition to pre-
supplied buffer, 35 ng of primer, 10–100 ng of viral RNA, 1 mM
dNTPs, 10 mM DTT, 25 U of RNAguard (Amersham, Little Chalfont,
United Kingdom), and 200 U of reverse transcriptase, was incubated
at 42 8C for 60 min and then at 94 8C for 2 min. The ﬁve cDNA
templates were then ampliﬁed using eight primer pairs, P1/P16, P2/
P22, P3/P30, P4/P38, P5/P45, P6/P53, P7/P60, and P8/P64, and
thermostable, recombinant Taq DNA polymerase. The reaction mix
(100 ll), which contained, in addition to pre-supplied buffer, 70 ng of
primer pair, 1 ll of RT reaction product, 200 lM dNTPs, 2 mM
MgCl2, and 2.5 U of DNA polymerase, was incubated at 94 8C for 1
min, then 94 8C for 20 s, 50 8C for 20 s, 68 8C for 3 min, for a total of
35 cycles and a ﬁnal 10-min extension at 68 8C. The PCR reaction
products were puriﬁed by ethanol precipitation using ammonium
acetate. Finally, sequence analysis was done using primers P1–P121
and standard cycle sequencing methods. Sequencing reaction mixes
(10 ll), which contained 70 ng of primer, 100 ng of PCR product, and
3 ll of cycle sequencing mix (BigDye Terminator v.3.1, Applied
Biosystems, Foster City, California, United States), were incubated at
96 8C for 10 s, 50 8C for 5 s, and 60 8C for 4 min, for a total of 25
cycles. The reaction products were puriﬁed by retention on a size
exclusion membrane (Montagee SEQ96, Millipore, Billerica, Massa-
chusetts, United States) as described by the manufacturer; eluted and
analyzed with an ABI 310 Prism Genetic Analyzer. Computer-assisted
analysis of sequence data was done using the Lasergene bio-
computing software (DNASTAR).
Supporting Information
Figure S1. Plaque Morphology of Alb ts17 Revertants
The plaque morphologies of Alb ts17L and Alb ts17S are illustrated.
Alb ts17 had a reversion (back mutation) frequency of 2 3 10
 6 and
there was a mixture of large and small plaques at 40 8C. The virus
from the small and large plaques produced progeny that formed
uniformly small or large plaques at 40 8C, respectively. At 30 8C, both
17RL and 17RS produced plaques of equal diameter and Alb 17RL
produced the same size plaques at 40 8C as the parental or wt MHV-
A59.
Found at DOI: 10.1371/journal.ppat.0010039.sg001 (1.7 MB PPT).
Table S1. Phenotypic Analysis of MHV-A59 ts Mutants
Found at DOI: 10.1371/journal.ppat.0010039.st001 (31 KB DOC).
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